New hope for Alzheimer’s patients

A study reveals the possibility of reversing the disease’s course by restoring an energy molecule in the brain

A recent study published by Fox News has highlighted promising prospects for reversing the progression of Alzheimer’s disease. Researchers were able to restore cognitive abilities and treat brain changes in laboratory mice by increasing the levels of a vital cellular energy molecule.

The research was based on the analysis of human brain tissue as well as tissue from affected mice, revealing a significant deficiency in NAD+, a key coenzyme responsible for energy production and cellular maintenance.

Scientists explained that NAD+ levels naturally decline with aging, weakening the ability of cells to carry out their essential functions.

In this context, contributing researcher Andrew A. Piper noted that when NAD+ levels fall below the required threshold, cells lose the ability to perform critical repair processes, posing a future threat to brain health.

Meanwhile, Charles Brenner, an expert in supplements that boost this coenzyme, emphasized that the brain — which consumes about 20% of the body’s total energy — relies entirely on NAD+ to repair DNA and enable neurons to withstand physiological stress.

These findings open the door to developing new treatments based on NAD+ supplements to support patients with Alzheimer’s and Parkinson’s disease by targeting the restoration of cellular energy. This represents a major shift in strategies aimed at promoting brain health and combating age-related cognitive decline.